Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer.
Saved in:
| Title: | Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer. |
|---|---|
| Authors: | Kverneland AH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Pedersen M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Westergaard MCW; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Nielsen M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Borch TH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Olsen LR; Section for Bioinformatics, DTU Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Aasbjerg G; Section for Bioinformatics, DTU Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Santegoets SJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Milne K; Deeley Research Centre, BC Cancer, Victoria, Canada., Nelson BH; Deeley Research Centre, BC Cancer, Victoria, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, Canada., Met Ö; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. |
| Source: | Oncotarget [Oncotarget] 2020 Jun 02; Vol. 11 (22), pp. 2092-2105. Date of Electronic Publication: 2020 Jun 02 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
